Cargando…

The Use of Liquid Sinemet in Routine Clinical Practice of Advanced Parkinson’s Disease: A Comparison of Available Options

BACKGROUND: Tablet formulations of Parkinson’s disease (PD) medications may become ineffective at managing motor fluctuations in advanced PD. The liquid formulation, levodopa carbidopa ascorbic acid solution, or LCAS, is an effective and inexpensive treatment for motor fluctuations however it remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Chee Boon, Danoudis, Mary, Paul, Eldho, Iansek, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357193/ https://www.ncbi.nlm.nih.gov/pubmed/37092237 http://dx.doi.org/10.3233/JPD-225117

Ejemplares similares

Patients' Perspective of Comprehensive Parkinson Care in Rural Victoria
por: Iansek, Robert, et al.
Publicado: (2020)

Health care experiences of people with Parkinson’s disease in Australia
por: Danoudis, Mary, et al.
Publicado: (2023)

Gait in Huntington’s disease and the stride length-cadence relationship
por: Danoudis, Mary, et al.
Publicado: (2014)

Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet(®)), sustained‐release carbidopa‐levodopa (Sinemet(®) CR), and carbidopa‐levodopa‐entacapone (Stalevo(®))
por: Hsu, Ann, et al.
Publicado: (2015)

THU154 The Effects Of Combined Arginine And Sinemet Stimulation On Copeptin Levels In The Pediatric Population
por: Sastry, Shruti, et al.
Publicado: (2023)

Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's Disease
por: McGinley, Jennifer L., et al.
Publicado: (2012)

Falls and mobility in Parkinson's disease: protocol for a randomised controlled clinical trial
por: Morris, Meg E, et al.
Publicado: (2011)

Health-related quality of life and strain in caregivers of Australians with Parkinson’s disease: An observational study
por: Kelly, David H, et al.
Publicado: (2012)

Comparison of gait in progressive supranuclear palsy, Parkinson’s disease and healthy older adults
por: Egerton, Thorlene, et al.
Publicado: (2012)

Matrix routines available at CERN
por: CERN. Geneva
Publicado: (1966)

High-volume postdilution hemodiafiltration is a feasible option in routine clinical practice
por: Marcelli, Daniele, et al.
Publicado: (2015)

Personalized Medicine in Parkinson’s Disease: New Options for Advanced Treatments
por: Mishima, Takayasu, et al.
Publicado: (2021)

AVAiLABLE NIS – AVASTIN® in lung cancer treatment in routine oncology practice in Germany
por: Zahn, Mark-Oliver, et al.
Publicado: (2019)

Pain following Craniotomy: Reassessment of the Available Options
por: Haldar, Rudrashish, et al.
Publicado: (2015)

Impact of External Cue Validity on Driving Performance in Parkinson's Disease
por: Scally, Karen, et al.
Publicado: (2011)

Further available immunization option to prevent pneumococcal disease
por: Vojtek, Ivo, et al.
Publicado: (2015)

Colorectal cancer screening: An updated review of the available options
por: Issa, Iyad A, et al.
Publicado: (2017)

Currently available treatment options for neuroendocrine liver metastases
por: Machairas, Nikolaos, et al.
Publicado: (2021)

Endobariatric procedures for obesity: clinical indications and available options
por: Goyal, Hemant, et al.
Publicado: (2021)

Impact of Deep Brain Stimulation on Daily Routine Driving Practice in Patients with Parkinson's Disease
por: Buhmann, Carsten, et al.
Publicado: (2015)

Routine Practice
por: Wells, P. P.
Publicado: (1883)

Biotropic liquid crystal phase transformations in cellulose-producing bacterial communities
por: Repula, Andrii, et al.
Publicado: (2022)

The options available in cognitive behavioral therapy to prevent chronification of insomnia
por: Crönlein, Tatjana, et al.
Publicado: (2011)

Pain management following spinal surgeries: An appraisal of the available options
por: Bajwa, Sukhminder Jit Singh, et al.
Publicado: (2015)

Traumatic submacular hemorrhage: available treatment options and synthesis of the literature
por: Casini, Giamberto, et al.
Publicado: (2019)

Coccydynia—The Efficacy of Available Treatment Options: A Systematic Review
por: Andersen, Gustav Ø., et al.
Publicado: (2021)

Hidradenitis suppurativa – biologic therapy and other available treatment options
por: Lipa, Katarzyna, et al.
Publicado: (2022)

Outcome of ABCA4 microarray screening in routine clinical practice
por: Ernest, Paul J.G., et al.
Publicado: (2009)

Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel
por: Kovács, Norbert, et al.
Publicado: (2022)

Option Volatility & Pricing Workbook: Practicing Advanced Trading Strategies and Techniques
por: Natenberg, Sheldon
Publicado: (2017)

New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results
por: Chaudhuri, K. Ray, et al.
Publicado: (2023)

Pricing quanto options with market liquidity risk
por: Gao, Rui, et al.
Publicado: (2023)

Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice
por: Price, David, et al.
Publicado: (2016)

A practical method for predicting frequent use of emergency department care using routinely available electronic registration data
por: Wu, Jianmin, et al.
Publicado: (2016)

Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
por: Batla, Amit, et al.
Publicado: (2016)

Off-time Treatment Options for Parkinson’s Disease
por: Fabbri, Margherita, et al.
Publicado: (2023)

Examining Routine Pediatric Vaccination Availability in Community Pharmacies in Washington State
por: McKeirnan, Kimberly Caye, et al.
Publicado: (2022)

Availability of healthier options in traditional and nontraditional rural fast-food outlets
por: Creel, Jennifer S, et al.
Publicado: (2008)

Treating mitochondrial disorders requires full exploitation of available therapeutic options
por: Finsterer, Josef, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_phnusa6qv5etdnuk97kmv33g8s